Multiple sclerosis (MS) is a demyelinating disease of the central nervous system (CNS) that leads to severe neurological deficits. Due to their immunomodulatory and neuroprotective activities and their ability to promote the generation of oligodendrocytes, mesenchymal stem cells (MSCs) are currently being developed for autologous cell therapy in MS. As aging reduces the regenerative capacity of all tissues, it is of relevance to investigate whether MSCs retain their pro-oligodendrogenic activity with increasing age.
| INTRODUCTION
Multiple sclerosis (MS) is an autoimmune demyelinating disease of the central nervous system (CNS), commonly with onset in young adulthood and progression throughout life (Reich, Lucchinetti, & Calabresi, 2018) . Therefore, the prevalence of MS is high in the aging population.
In response to demyelination, CNS-resident oligodendrocyte progenitor cells (OPCs) become activated, proliferate, and migrate to the lesion and differentiate into new oligodendrocytes, completing remyelination (Franklin & Ffrench-Constant, 2017) . While in MS and in other demyelinating diseases, remyelination occurs efficiently in young adults, with aging OPCs' differentiation and maturation into oligodendrocytes declines, becoming a limiting factor for spontaneous remyelination (Sim, Zhao, Penderis, & Franklin, 2002) .
Mesenchymal stem cells (MSCs) are undifferentiated multipotent stromal cells able to generate osteoblasts, adipocytes as well as chondrocytes, and capable of modulating the microenvironment through paracrine signals (Minguell, Erices, & Conget, 2001) . Therefore, MSCs are viewed as cells with many potential clinical applications, in particular as autologous cell therapies (for review see Ding, Shyu, & Lin [2011] ). In the context of MS, MSCs have several potential benefits.
They are immunomodulatory and can therefore be used to reduce the tissue damage resulting from acute inflammatory episodes that are typical for the early stages of the disease. Indeed, transplanted MSCs are immunomodulatory and neuroprotective promoting functional recovery in MS animal models (Bai et al., 2009 (Bai et al., , 2012 and apparently elicit beneficial effects in human MS patients (Connick et al., 2012) .
MSCs' potential role in myelin regeneration is still being explored.
While MSCs do not directly transdifferentiate to myelin-producing cells (Hunt et al., 2008) , there is accumulating evidence suggesting that MSCs might beneficially influence remyelination by modulating endogenous progenitor activities. We have previously demonstrated that soluble factors derived from MSCs induce an oligodendrocyte fate on neural stem cells (NSCs; Rivera et al., 2006; Steffenhagen et al., 2012) and enhance OPC differentiation (Jadasz et al., 2013) . Furthermore, cotransplantation of NSCs together with MSCs onto organotypic hippocampal slice cultures promoted oligodendrocyte differentiation of the transplanted NSCs (Rivera et al., 2009) . Also, MSCs grafted into the fimbria of cuprizoneinduced demyelinated mice significantly activated OPCs and supported remyelination (Jaramillo-Merchan et al., 2013) . This capacity of MSCs to promote oligodendrogenesis is not restricted to rodents as soluble factors derived from human MSCs induce oligodendrocyte differentiation in human induced pluripotent stem cell-derived NSCs (Jadasz et al., 2018) . In summary, MSC transplantation might be developed into a potentially powerful MS therapy (Connick et al., 2012; Freedman et al., 2010; Jadasz, Aigner, Rivera, & Kury, 2012) . Here we ask whether MSCs retain their capacity to enhance the generation of new oligodendrocytes with aging.
| MATERIALS AND METHODS

| Animal subjects
Two-month-old and 17-20 months old male and female Fischer 344 rats (Charles River Deutschland GmbH, Germany) were used as young and 
| MSC cultures
MSC cultures from young and old rats were performed as previously described (Rivera et al., 2008) . Briefly, bone marrow (BM) plugs were harvested from femurs and tibias of young (y; 2-month-old) and old (o; 17-to 20-month-old) male and female Fisher-344 rats (Charles River Deutschland GmbH, Germany). Plugs were mechanically dissociated in αMEM (Gibco Invitrogen, Karlsruhe, Germany) and recovered by centrifugation. Cell pellets were resuspended in αMEM containing 10% FBS (PAA, Austria) and 1% Penicillin/Streptomycin (PAN Biotech GmbH, Aiden Bach, Germany) (αMEM-10% FBS) and seeded at 1 × 10 6 cells/cm 2 . After 3 days, medium was changed, and nonadherent cells were removed. Adherent cells were incubated in fresh αMEM-10% FBS until a confluent layer of cells was achieved. Cells were trypsinized using 0.25% Trypsin (Gibco Invitrogen, Karlsruhe, Germany) and seeded in αMEM-10% FBS at 8,000 cells/cm 2 . After 3-5 days of culture, the resulting monolayer of cells, hereafter named rat bone marrow-derived MSCs, was trypsinized and further cultured for experiments or frozen for later use. As demonstrated in our previous work, this cell culture preparation is highly enriched in multipotent MSCs with no more than 4.5% of hematopoietic contamination (Rivera et al., 2006) . We named yMSCs when cells were isolated from young rats (2-monthold) and oMSCs (17-to 20-month-old) when were isolated from old animals.
| NSC cultures
Tripotent NSCs derived from rat hippocampus were generated as described (Wachs et al., 2003) . Briefly, hippocampi from 2-month-old male and female Fisher-344 rats (Charles River Deutschland GmbH, Germany)
were aseptically removed and dissociated. Cells were resuspended in Neurobasal-A medium (NB-A; Gibco BRL, Germany) supplemented with B27 (Gibco BRL, Germany), 2 mM L-glutamine (PAN, Germany), 100 U/mL penicillin/0.1 mg/L streptomycin (PAN, Germany), hereafter referred to as NB/B27. For maintenance and expansion of the cultures, the NB/B27 was further supplemented with 2 mg/mL heparin (Sigma, Germany), 20 ng/mL FGF-2 (R&D Systems, Germany), and 20 ng/mL EGF (R&D Systems, Germany). As previously described (Rivera et al., 2006) , immediately after plating of dissociated neurospheres in NB/B27-5% FBS, around 90% of the NSCs expressed the neural stem and progenitors markers such as nestin and A2B5. Cultures were maintained at 37 C in a humidified incubator with 5% CO 2 . Neurosphere cultures from passage number 2-6 were used throughout this study and termed NSCs. OPCs were cultured in Sato media supplemented with 10 ng/mL of PDGF-AA and 10 ng/mL bFGF (Peprotech, Rocky Hill, NJ) to keep the cells in the proliferative stage.
| OPCs cultures
| Organotypic cerebellar slices cultures
Demyelinating rat cerebellar slice cultures were prepared as previously described (Birgbauer, Rao, & Webb, 2004 
| MSC-conditioned media preparation
For experiments performed in NSCs, MSC-conditioned medium (MSC-CM) was prepared as described (Rivera et al., 2006 
| Bioluminescence assays
Bioluminescence assays were performed using noncommercial dual luciferase enzyme assay system. In this system, NSCs were cotransfected with (a) plasmid containing MBP promoter driving the expression of firefly luciferase (pMBP-Luci); (b) control vector that contains the cytomegalovirus (CMV) promoter driving the expression of Renilla luciferase (Promega, Mannheim, Germany). The two different luciferases use different specific substrates and therefore, the MBP regulatory region driven firefly luciferase activity was distinguished from Renilla luciferase. Technologies, HVD, Austria) and luciferase activity was determined.
In all conditions, firefly luciferase activity was normalized against the Renilla luciferase activity.
2.9 | NSCs, OPCs, and demyelinated cerebellar slices stimulation with yMSC-CM and oMSC-CM NSCs were treated with yMSC-CM and oMSC-CM as previously described (Rivera et al., 2006) . Briefly, NSCs were plated overnight onto poly-ornithine (250 μg/mL) and laminin (5 μg/mL)-coated glass coverslips at a density of 12,000 cells/cm 2 in αMEM-10% FBS. Next, media was replaced and cells were incubated either with yMSC-CM or oMSC-CM.
NSCs were alternatively incubated in αMEM-10% FBS as control condi- After exposure to lysolecithin, demyelinated cerebellar slices were incubated with organotypic slice medium-based yMSC-CM or oMSC-CM. Unconditioned organotypic slice medium was used as control.
Treatment was replaced every other day and slices were collected at 2 and 6 days in vitro (DIV) post demyelination and fixed with 4% PFA for 1 hr. Then slices were stored in phosphate-buffered saline (PBS) 1×
at −20 C for immunostaining. Olig2 that also expressed the other mature OPC markers was determined in at least three independent experiments.
| Immunocytochemistry and analysis
| Focal demyelination lesions
Male Fischer 344 rats aged 12 months were used to induce bilateral focal demyelination in the caudal cerebellar peduncle (CCP) in compliance with UK Home Office regulations (Project License: 70/7715, formerly 80/2228). Animals were anesthetized using a combination of 2% isoflurane in oxygen (as carrier gas) and a subcutaneous injection of buprenorphine hydrochloride 0.03 mg/kg (Vetergesic, Animalcare Ltd, Hull, UK). The procedure consisted on bilateral stereotactical injections of 4 μL of 0.01% ethidium bromide (v/v) into the CCP, −11.6 mm caudal, ±2.9 mm lateral, and −8.3 mm ventral from bregma (Woodruff & Franklin, 1999) . 2.14 | Immunohistochemistry Fluorochrome-conjugated secondary antibodies: Donkey AF488 antirabbit (1:500; Invitrogen), Donkey AF488 anti-goat (1:500; Invitrogen), Donkey AF568 anti-rabbit (1:500; Invitrogen), and Donkey AF647 anti-mouse (1:500; Invitrogen).
| MSCs stable transfection with mCherry
F I G U R E 1 Legend on next page. 
| Histological analysis and quantification
| Oil red-O staining
Sections from control and treatment group were left to dry at room temperature and then placed in a Coplin jar containing propylene glycol (100%) for 5 min. Prewarmed Oil Red-O solution (0.5% in propylene glycol, Sigma-Aldrich) was stained at 65 C for 10 min. Following incubation for 5 min with differentiation solution (85% propylene glycol), slides were rinsed twice with water and then mounted using a jelly-based mounting media. Representative images of Oil Red-O stained lesions were digitized, and, using ImageJ software, the intensity of the lesion area was measured from the red channel. Data are given as mean ± SEM and statistically analyzed. Three sections per marker per animal were analyzed, and a minimum of four animals were used.
| Statistical analysis
Data are presented as means ± SD and statistical analysis was performed using PRISM4 (GraphPad, San Diego, CA) and SPSS (IBM, However, yMSC-CM displays a higher effect on MBP-positive cells than oMSC-CM. Values are displayed as mean ± SD. Experiment was performed in tetraplicate. One-way ANOVA and the Tukey post hoc test were used for statistical analysis. **p < .01; *** p < .001. NSCs were transfected with MBP promoter-Luci vector and incubated for 3 days under control medium, yMSC-CM and oMSC-CM. Cells were also exposed for 3 days to different MSC-CM dilutions. Quantification of bioluminescence data shows MBP promoter activation (as luciferase activity) in NSCs either treated in the conditions previously mentioned (o) or treated with increasing doses of yMSC-CM and oMSC-CM (p). Note that although both yMSC-CM and oMSC-CM induce an increase of the MBP promoter activity with respect to control, yMSC-CM displays a higher effect than oMSC-CM. Values are displayed as mean ± SD. Experiment was performed in triplicate. One-way ANOVA and the Tukey post hoc test as well as two-way ANOVA (p) were used for statistical analysis. *p < .05; **p < .01 (o) and p values given in graph title indicate a significant difference between MSC-CM ages (p)
oligodendrocytes (Figure 1f -h and j-l, respectively). Both yMSC-CM and oMSC-CM decreased the proportion of GFAP-expressing astrocytes compared to the control condition to a similar extent (Figure 1n ). Thus, regardless of donor age, soluble factors derived from MSCs are able to induce an oligodendrocyte fate at the expense of astrogenesis. However, although both yMSC-CM and oMSC-CM increased the proportion of MBP-expressing oligodendrocytes compared to the control, yMSC-CMinduced a higher percentage of MBP-positive cells than oMSC-CM in F I G U R E 2 Aged MSCs display a reduced ability to promote OPC differentiation. Neonatal OPCs were incubated in control serum free Sato media (a and e) and yMSC (b and f) and oMSC (c and g) conditioned serum-free Sato media for 2 and 4 days in vitro (DIV). Fluorescent images indicate the expression of differentiation CNP (red) and mature oligodendrocyte MBP (red) markers together with the pan oligodendrocyte lineage marker Olig2 (green). DAPI nuclear staining is shown in all fluorescent images. Quantitative analysis shows the percentage of CNP-Olig2 (i and j) or MBP-Olig2 (k and l) double-positive cells within the Olig2 expressing cells at 2 and 4 days of incubation. Scale bars = 50 μm. Note that both, yMSC-CM and oMSC increase OPC differentiation when compared to control. However, oMSC-CM displays a delayed and less effective activity in OPCs as is only evident at 4 days of incubation and not so pronounced when compare to yMSC-CM. Values are displayed as mean ± SD. Experiments were done in triplicate. Statistics were performed by one-way ANOVA and the Tukey post hoc test. *p < .05; **p < .01; ***p < .001
NSCs (Figure 1m ). Bioluminescence assays were used to confirm these findings. Although both yMSC-CM and oMSC-CM-induced an increase In summary, both young and aged MSCs can promote the generation of oligodendrocytes, although aged MSCs do so less successfully.
F I G U R E 3 Soluble factors derived from yMSCs but not from oMSCs enhance myelin-like sheath formation ex vivo. Cerebellar slices from P9 rats were cultured ex vivo and exposed for 16 hr to lysolecithin to induce demyelination. Thereafter, demyelinated slices were incubated in control organotypic slice media, yMSC-CM and oMSC-CM for up to 6 days. Fluorescent images show the expression of Neurofilament H (red) as a marker of axons together with the mature oligodendrocyte marker MBP (green) present in the myelin-like sheaths, as an indicator of myelination at 2 and 6 days in vitro (DIV) after lysolecithin-induced demyelination (a). Scale bar = 100 μm. Quantitative analysis shows the ratio between the area of the slice where NFH colocalizes with MBP and NFH area (b) . Note that after 6 DIV only yMSC-CM enhances ex vivo myelin-like sheath formation while oMSC-CM leads to similar myelination levels when comparing to control condition. Values are displayed as mean ± SD. Experiments are done in triplicate (duplicate for oMSC-CM). Statistic was performed by two-way ANOVA and Bonferroni post hoc test. p values in the graph title indicate significant difference between the conditions tested. *p < .05
Only transplanted MSCs derived from young donors boost OPC differentiation during CNS remyelination. Twelve months old rats were demyelinated by ethidium bromide (EtBr) injection into the caudal cerebellar peduncle (a). One, two, and three days after demyelination, rats were systemically transplanted with yMSCs or oMSCs that express mCherry for their future detection (b). PBS is used as vehicle control. Fluorescent image shows the presence of mCherry-expressing MSCs in the demyelinated area at 21 days post-lesion (dpl) (c). Scale bar = 200 μm. Fluorescent images show the presence of OPCs (Olig2+/APC−) and the generation of new oligodendrocytes (Olig2+/APC+) in the lesion site of the different animal groups (d). Hoechst shows nuclei counterstaining. Dashed lines denote demyelinating lesion area (L). Scale bar = 100 μm. In merge images, the inset shows a magnification of the area delimited by the square. Quantitative analysis shows the number of all oligodendroglial lineage cells (Olig2+), OPCs, and differentiated oligodendrocytes within the demyelinated lesion area (mm 2 ) of the distinct animal groups at 21 dpl (e). Note that only the animals that were transplanted with yMSCs display a higher number of differentiated oligodendrocytes (Olig2+/APC+) within the lesion site. Values are displayed as mean ± SD. Five animals were analyzed for the PBS group while four animals were analyzed for the group transplanted either with yMSCs or oMSCs. Statistics were performed by one-way ANOVA and the Tukey post hoc test. *p < .05; NS, not significant 3.2 | Aging suppresses the ability of MSC-CM to enhance ex vivo generation of myelin-like sheaths Does the reduced oligodendrogenic activity of oMSCs have a further consequence on CNS regeneration? Remyelination is highly efficient in young individuals, but this efficiency declines with aging (Shields, Gilson, Blakemore, & Franklin, 1999; Sim et al., 2002) . Therefore, we next asked whether MSC derived soluble factors could not only increase OPC differentiation but also enhance myelination and, if so whether aging might affect this activity. To address these questions we used a well-established ex vivo myelination model, where organotypic cerebellar slice cultures are shortly exposed to lysolecithin to provoke demyelination (Birgbauer et al., F I G U R E 5 Legend on next page.
2004; Jarjour, Zhang, Bauer, Ffrench-Constant, & Williams, 2012; Zhang, Jarjour, Boyd, & Williams, 2011) . For this experiment, yMSC-CM and oMSC-CM were prepared exposing MSCs to basic organotypic slice culture medium and the unconditioned medium was used as control. Upon lysolecithin exposure, demyelinated slices were incubated in control medium, yMSC-CM or oMSC-CM and were fixed at 2 and 6 days in vitro (DIV) post demyelination (Figure 3a) . Generation of myelin-like sheaths around the axons was determined by the ratio between the MBP/NF-H colocalization area (myelinated axons) and the total NF-H area (overall axons). This often equates to compact myelin formation in this model (Zhang et al., 2011 ) (for more details see Supporting Information Movie S1). Slices exposed to yMSC-CM showed an increase in myelination when compared to control, while there was no difference between control and oMSC-CM treated slices (Figure 3b) . Hence, aging suppresses the ability of MSCs to stimulate the generation of oligodendrocytes and subsequent myelin-like sheath formation in an ex vivo model.
| Aging interferes with the capacity of MSCs to enhance OPC differentiation during CNS remyelination in vivo
We further explored whether the age-related restriction in the ability of MSCs to promote the generation of oligodendrocytes and enhance remyelination is also observed in an in vivo context. We systemically transplanted, through the tail vein, 4.5-6.0 × 10 6 mCherry-expressing yMSCs or oMSCs in adult rats after bilateral demyelination of the caudal cerebellar peduncles (CCP) (Figure 4a ,b; Woodruff & Franklin, 1999) . PBS intravenous administration was used as a vehicle control. In this model, OPC differentiation occurs very efficiently in young animals, however, it is impaired with increasing age. Rats older than 12 months already display a reduced rate of OPC differentiation contributing to a significant delay in remyelination compared to young animals (<3 months; Shields et al., 1999; Sim et al., 2002) . Therefore, middle age rats (12 months old) were used and sacrificed at 21 days post-lesion (dpl) to assess treatment efficiency.
We used mCherry labeling to evaluate whether systemically transplanted MSCs survive and reach the lesion area and, most likely, exert a paracrine impact on neighboring CNS-resident cells. Following the mCherry signal, we found that transplanted MSCs were able to reach the demyelinating lesion (Figure 4c) (Figure 4d,e) . During remyelination, activated and proliferating OPCs can be detected by the expression of the transcription factor Nkx2.2 and Ki67, respectively (Watanabe, Hadzic, & Nishiyama, 2004 Figure S3a ,b). These findings together suggest that MSCs increased the number of new oligodendrocytes generated by boosting OPC differentiation instead of indirectly enhancing OPC proliferation.
As expected, none of the mCherry positive cells were found to coexpress Olig2 (Supporting Information Figure S4 ), arguing against transdifferentiation of transplanted MSCs to oligodendrocytes.
During remyelination, OPC differentiation is favored by antiinflammatory (M2) macrophages/microglia and inhibited by the presence of myelin debris (Miron et al., 2013) . Therefore, we evaluated whether Schwann cell marker (Zawadzka et al., 2010) , in response to F I G U R E 5 Independently from donors age, transplanted MSCs do not alter macrophage/microglia response during CNS remyelination. Twelve months old rats were demyelinated by ethidium bromide injection into the caudal cerebellar peduncle. One, two, and three days after demyelination, rats were systemically transplanted with mCherry-expressing yMSCs or oMSCs. PBS is used as vehicle control. Fluorescent images show the lesion site of the different animal groups at 21 dpl, the presence of macrophages/microglia (Iba1+) and their expression of mannose receptor (MR+) evidencing M2 anti-inflammatory state (a). Hoechst shows nuclei counterstaining. Dashed lines denote demyelinating lesion area (L). Scale bar = 100 μm. In merge images, the inset shows a magnification of the area delimited by the square. Quantitative analysis shows the number of macrophage/microglia cells (Iba1+) and the number of anti-inflammatory cells (MR+) within the lesion area (mm 2 ) as well as the proportion of anti-inflammatory cells among the total macrophage/microglia cell population (MR+/Iba1+) (b). Note that none of transplanted groups shows significant difference on the macrophage/microglia parameters measured respect to vehicle group. Phase contrast images show oil red O (ORO) staining to detect the presence of myelin debris within the lesion site in the different animal group at 21 dpl (c). Scale bar = 100 μm. Quantification analysis shows the mean relative ORO intensity per lesion area (mm 2 ) (d). Note that none of transplanted groups shows a significant difference in the clearance of myelin debris respect to vehicle group. Values are displayed as mean ± SD. Five animals were analyzed for the PBS group while four animals were analyzed for the group transplanted either with yMSCs or oMSCs. Statistics were performed by one-way ANOVA and the Tukey post hoc test. NS, not significant F I G U R E 6 Independently from donors age, transplanted MSCs do not alter the presence of Schwann cells during CNS remyelination. Twelve months old rats were demyelinated by ethidium bromide injection into the caudal cerebellar peduncle. One, two, and three days after demyelination, rats were systemically transplanted with mCherry-expressing yMSCs or oMSCs. PBS is used as vehicle control. 
| DISCUSSION
Aging affects homeostasis and reduces the regenerative capacity of various tissues and organs (Alt et al., 2012; Fulle et al., 2012; Ruckh et al., 2012 Aging decreases OPC differentiation and impairs endogenous CNS remyelination (Franklin & Ffrench-Constant, 2008; Shen et al., 2008; Shields et al., 1999; Sim et al., 2002) . Nevertheless, in a previous study, it has been shown that remyelination efficiency in old animals can be restored after exposure to a youthful systemic milieu via heterochronic parabiosis (Ruckh et al., 2012) or treatment with molecules such as 9-cis retinoic acid (Huang et al., 2011) . Together, these observations suggest that age-related myelin regeneration restrictions can be overcome by the contribution of a strong regenerative microenvironment or stimulus. Here, we observed an enhancement in OPC differentiation during remyelination Thus, we assume that 17-20 month old rats have a chronological/biological age of later stage MS patients, which are currently in the scope of MSC-MS trials.
Since MSCs display immunomodulatory and neuroprotective activities, systemic autologous MSC therapy has been proposed for the treatment of MS (Connick et al., 2012; Freedman et al., 2010) .
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